Remove 2024 Remove HIV Treatment and Prevention Agents Remove Hospitals
article thumbnail

Tranq dope (fentanyl-xylazine combination): A new horizon in opioid withdrawal treatment

ALiEM - Pharm Pearls

Bupe Allergy Buprenorphine induction has been the mainstay of emergency department treatment of opioid use disorder for more than a decade [11, 12]. Of note, screening is often required for insurance approval for substance use treatment. 2024 study [16]. Prolonged QTc was defined as >450 msec.

article thumbnail

NHC Comments on CMS 2026 Notice of Benefit and Payment Parameters

Putting Patients First Blog

Recognizing PrEP as a preventive service rather than as indicative of an active medical condition, as HHS proposes, could help address the current risk selection seen in the market. Clear guidance on the treatment of rebates within the ACF will help avoid distortions in pricing and prevent patients from bearing disproportionate costs.

article thumbnail

Year In Review: Top Infectious Diseases Articles From 2024

ID Stewardship

In this articlea selection of notable peer-reviewed publications from 2024 are provided. BCPS, BCIDP 2024 has been an interesting year forinfectious disease literature dissemination. As 2024 comes to a close, my friend Dr. RANDOMIZED CONTROLLED TRIALS 1. Article Selection by: Bassam Ghanem, Pharm.D., Gauthier, Pharm.D.,